HRMY

Harmony Biosciences Holdings Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth↑ 8/10
  • Momentum↓ 2/10
Harmony Biosciences Holdings sales and earnings growth
HRMY Growth
Good
  • Revenue Y/Y↑ 21.13%
  • EPS Y/Y↑ 50.23%
  • FCF Y/Y↑ 34.84%
Harmony Biosciences Holdings gross and profit margin trends
HRMY Profitability
Great
  • Gross margin ↑ 77.70%
  • EPS margin↑ 22.50%
  • ROIC↑ 55.80%
Harmony Biosciences Holdings net debt vs free cash flow
HRMY Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 16.1

Harmony Biosciences Holdings stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗